GLAXO DERMATOLOGY TARGETING JANUARY LAUNCH OF ALLERGEN PATCH TEST
This article was originally published in The Gray Sheet
Executive Summary
GLAXO DERMATOLOGY TARGETING JANUARY LAUNCH OF ALLERGEN PATCH TEST for contact dermatitis, "a common skin rash caused by substances that are often found in many household, commercial and cosmetic preparations, in addition to chemicals used to make hats, clothes and shoes," Glaxo said in a Nov. 29 release. The thin-layer, rapid-use epicutaneous test, or T.R.U.E. Test, received licensing approval Nov. 22 from FDA's Center for Biologics Evaluation and Research.